… shown clinical efficacy in patients with anaemia of non-dialysis (ND) and dialysis-dependent
(… in ND-CKD used roxadustat as active treatment and enrolled ESA-naïve patients (Table 1). …

… patients with chronic kidney disease (CKD) who are receiving dialysis treatment have anemia…
roxadustat involving patients who were undergoing dialysis in China, 15 along with pooled …

… level, which is a favorable therapy approach for patients who do not receive hemodialysis. …
patient’s kidneys, and aggravating the anemia [18]. In this study, we observed that Roxadustat …

… patients receiving subcutaneous ESA injections. Some HIF prolyl hydroxylase inhibitors (eg,
roxadustat… and benefits of treatments for anemia in non– dialysis-dependent populations …

… Another patient initiated hemodialysis without reporting a … during the treatment period occurred
before achieving anemia … a major portion of the roxadustat treatment period in this study. …

… Roxadustat is an oral hypoxia inducing factor-prolyl … regulates iron metabolism in patients
with chronic kidney disease (CKD) … of roxadustat in regulating iron metabolism in patients with …

… not be generally applicable to patients of other ethnicities or geographic locations. Overall,
this study showed that treatment with oral roxadustat … -CKD patients with anemia who were …

… Background: Chronic kidney disease (CKD) patients often grapple with … Background:
Roxadustat has been approved for patients with chronic kidney disease(CKD) and renal anemia in …

… ESA responsiveness and slower declining rate of residual kidney function in PD patients,
and that HD patients experience more chronic blood loss because of red blood cell destruction …

… The incidence of chronic kidney disease (CKD) in China is 10.8%[1]. … to research if roxadustat
could further improve the compliance of anemia treatment in peritoneal dialysis patients. …